Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rakovina Therapeutics Inc. has increased its private placement offering to $2.5 million in response to high investor demand. The funds will support the advancement of novel cancer treatments using AI platforms and the development of its kt-3000 series. The offering consists of units priced at $0.06, each including a share and a warrant.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.